115480 — CU Medical Systems Income Statement
0.000.00%
Last trade - 00:00
- KR₩35bn
- KR₩49bn
- KR₩42bn
R2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27,931 | 28,319 | 35,402 | 46,957 | 41,803 |
Cost of Revenue | |||||
Gross Profit | 12,416 | 12,487 | 18,476 | 24,701 | 20,403 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 27,430 | 38,362 | 37,116 | 36,462 | 39,518 |
Operating Profit | 501 | -10,043 | -1,714 | 10,496 | 2,285 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4,368 | -18,290 | -15,140 | 10,446 | -7,443 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,355 | -20,749 | -14,141 | 9,511 | -8,136 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2,911 | -25,740 | -13,981 | 9,425 | -8,204 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2,911 | -25,740 | -13,981 | 9,425 | -8,204 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -167 | -639 | -240 | 204 | -136 |
Dividends per Share |